169 related articles for article (PubMed ID: 2370329)
1. Screening and surveillance of patients at high risk for malignant melanoma result in detection of earlier disease.
Masri GD; Clark WH; Guerry D; Halpern A; Thompson CJ; Elder DE
J Am Acad Dermatol; 1990 Jun; 22(6 Pt 1):1042-8. PubMed ID: 2370329
[TBL] [Abstract][Full Text] [Related]
2. Monitoring of kindreds with hereditary predisposition for cutaneous melanoma and dysplastic nevus syndrome: results of a Swedish preventive program.
Hansson J; Bergenmar M; Hofer PA; Lundell G; Månsson-Brahme E; Ringborg U; Synnerstad I; Bratel AT; Wennberg AM; Rosdahl I
J Clin Oncol; 2007 Jul; 25(19):2819-24. PubMed ID: 17602087
[TBL] [Abstract][Full Text] [Related]
3. [Malignant melanoma--a warning. How to reduce mortality?].
Volden G; Rajka G; Thune P; Falk ES; Krogh HK
Tidsskr Nor Laegeforen; 1990 Apr; 110(10):1202-5. PubMed ID: 2333644
[TBL] [Abstract][Full Text] [Related]
4. Multiple primary melanomas.
Stam-Posthuma JJ; van Duinen C; Scheffer E; Vink J; Bergman W
J Am Acad Dermatol; 2001 Jan; 44(1):22-7. PubMed ID: 11148472
[TBL] [Abstract][Full Text] [Related]
5. [Nevi, sun and the risk of melanoma].
Snellman E; Koulu L; Rantanen T
Duodecim; 2002; 118(4):359-66; quiz 366, 401. PubMed ID: 12233040
[No Abstract] [Full Text] [Related]
6. Atypical mole syndrome: risk factor for cutaneous malignant melanoma and implications for management.
Slade J; Marghoob AA; Salopek TG; Rigel DS; Kopf AW; Bart RS
J Am Acad Dermatol; 1995 Mar; 32(3):479-94. PubMed ID: 7868720
[TBL] [Abstract][Full Text] [Related]
7. Age at diagnosis and transmission of invasive melanoma in 23 families with cutaneous malignant melanoma/dysplastic nevi.
Goldstein AM; Fraser MC; Clark WH; Tucker MA
J Natl Cancer Inst; 1994 Sep; 86(18):1385-90. PubMed ID: 8072031
[TBL] [Abstract][Full Text] [Related]
8. Dysplastic nevi. Markers for increased risk for melanoma.
Rigel DS; Rivers JK; Kopf AW; Friedman RJ; Vinokur AF; Heilman ER; Levenstein M
Cancer; 1989 Jan; 63(2):386-9. PubMed ID: 2910446
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness and causes for failure of surveillance of CDKN2A-mutated melanoma families.
van der Rhee JI; de Snoo FA; Vasen HFA; Mooi WJ; Putter H; Gruis NA; Kukutsch NA; Bergman W
J Am Acad Dermatol; 2011 Aug; 65(2):289-296. PubMed ID: 21570154
[TBL] [Abstract][Full Text] [Related]
10. Dysplastic nevus--a risk factor of developing skin melanoma clinical and epidemiological study with retrospective review of literature.
Marinković M; Janjić Z; Nikolić J
Med Pregl; 2011; 64(5-6):315-8. PubMed ID: 21789925
[TBL] [Abstract][Full Text] [Related]
11. A high incidence of melanoma found in patients with multiple dysplastic naevi by photographic surveillance.
Kelly JW; Yeatman JM; Regalia C; Mason G; Henham AP
Med J Aust; 1997 Aug; 167(4):191-4. PubMed ID: 9293264
[TBL] [Abstract][Full Text] [Related]
12. The dangers of atypical mole (dysplastic nevus) syndrome. Teaching at-risk patients to protect themselves from melanoma.
Marghoob AA
Postgrad Med; 1999 Jun; 105(7):147-8, 151-2, 154 passim. PubMed ID: 10376056
[TBL] [Abstract][Full Text] [Related]
13. Dysplastic (atypical) nevi: significance and management.
Lober CW
South Med J; 1992 Sep; 85(9):870-7. PubMed ID: 1523445
[TBL] [Abstract][Full Text] [Related]
14. Dysplastic nevi.
Farber MJ; Heilman ER; Friedman RJ
Dermatol Clin; 2012 Jul; 30(3):389-404. PubMed ID: 22800547
[TBL] [Abstract][Full Text] [Related]
15. Supply-and-demand discrepancy in academic pigmented lesion clinics: a case for a new health care delivery model.
Vickery EL; Seidler EM; Jones TE; Veledar E; Chen SC
JAMA Dermatol; 2014 Nov; 150(11):1167-72. PubMed ID: 25028988
[TBL] [Abstract][Full Text] [Related]
16. Dysplastic nevi and malignant melanoma.
Crutcher WA; Cohen PJ
Am Fam Physician; 1990 Aug; 42(2):372-85. PubMed ID: 2200246
[TBL] [Abstract][Full Text] [Related]
17. Prevention and early detection of malignant melanoma.
Edman RL; Wolfe JT
Am Fam Physician; 2000 Nov; 62(10):2277-85. PubMed ID: 11126854
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis and treatment of early melanoma. NIH Consensus Development Conference. January 27-29, 1992.
Consens Statement; 1992 Jan 27-29; 10(1):1-25. PubMed ID: 1515516
[TBL] [Abstract][Full Text] [Related]
19. Screening program reduced melanoma mortality at the Lawrence Livermore National Laboratory, 1984 to 1996.
Schneider JS; Moore DH; Mendelsohn ML
J Am Acad Dermatol; 2008 May; 58(5):741-9. PubMed ID: 18068264
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the American Academy of Dermatology's National Skin Cancer Early Detection and Screening Program.
Koh HK; Norton LA; Geller AC; Sun T; Rigel DS; Miller DR; Sikes RG; Vigeland K; Bachenberg EU; Menon PA; Billon SF; Goldberg G; Scarborough DA; Ramsdell WM; Muscarella VA; Lew RA
J Am Acad Dermatol; 1996 Jun; 34(6):971-8. PubMed ID: 8647990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
